Press Releases

There are already almost 300 gene and cell therapies in the research and development phase to treat a hundred diseases

13:45 Farmaindustria
R&D efforts in this area have already achieved several effective treatments against different pathologies

Europe approved 42 completely new medicines in 2018, 20% more than in the previous year

10:39 Farmaindustria
Cancer, infectious diseases, haematology and neurology made up the majority of the new additions, which also included three gene and cell therapies.

One in four positive rulings of the EMA were aimed at treatments for rare diseases

The pharmaceutical industry advocates for collaboration with other healthcare stakeholders to achieve new advances in health

12:38 Farmaindustria
The international federation of the research-based pharmaceutical industry, IFPMA, has renewed its commitment to global health progress in celebration of its 50th anniversary

The pharmaceutical industry can claim several examples of success in recent decades such as vaccines, the fight against HIV and cancer and also the cure for Hepatitis C

In Spain, almost half of the €1,100 million that the pharmaceutical industry invests in R&D is dedicated to collaboration projects with centres and external parties

The Government and Farmaindustria renew the Agreement for Sustainability, Access and Innovation

17:37 Farmaindustria
The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System

Parliamentarians, health care professionals and associations defend the need for patients to actively participate in the public sphere in Spain

18:03 Farmaindustria
FARMAINDUSTRIA remarks that patients are the raison d'etre for those who are part of the health care system

The European biomedical industry urges the United Kingdom and the EU to protect patients’ access to medicines before Brexit

11:47 Farmaindustria
The associations that represent the European and British biomedical industry insist on the importance of ensuring cooperation between the United Kingdom and the European Union in terms of pharmaceutical regulation

The General Council of Spanish Advocacy and Transparency International reward the pharmaceutical industry’s commitment to transparency

13:48 Farmaindustria
They recognise that the Code of Good Practice "guarantees that relationships with professionals and health organizations are developed under strict ethical principles".

R&D and training continue to be the basis for collaboration between the pharmaceutical industry and healthcare professionals

14:37 Farmaindustria
For a second year running, the companies adhering to FARMAINDUSTRIA's Transparency Code publish the collaborations with sector agents

Transparency, sustainability and innovation, pillars of the social commitment of the pharmaceutical industry

17:47 Farmaindustria
FARMAINDUSTRIA approves its annual report of activities in the Association’s Ordinary General Assembly

The innovative pharmaceutical industry is the leader in stable, qualified and female employment

13:33 Farmaindustria
In 2016, the industry hired 4,285 workers accounting for 11% of its workforce, and the total number of jobs reached 39,392

93% are permanent employees, compared to 74% of the Spanish economy, and one in three new contracts is for young people

59% are university graduates, compared to 42% of the average in Spain

Female employment is 51%, twice the average of other industrial sectors, and with the highest pay equity between men and women
Logo de Pacto Digital para la Protección de las Personas
Logo de Pacto Digital para la Protección de las Personas

© 2024 FarmaIndustria All rights reserved